Recent Updates
Recently added Catalysts

Supplemental parenteral nutrition

Phase 2

Critical Illness | Unknown | Other |Baxter International Inc.|Last Updated: May 24, 2024

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedNO_TREATMENT_CONTROLLED
Total Trials1
Total Enrollment240
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT03292237Intensive Nutrition in Critically Ill AdultsPHASE2 COMPLETED 240Oct 15, 2018Jul 31, 2023May 24, 202423 Australia, New Zealand
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Daily energy delivered from nutrition therapy
Day 28
Secondary Endpoints
Nutrition intake
Day 28
Duration hospital stay
Day 28
Ventilator Free Days
Day 28
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeSUPPORTIVE_CARE
Treatment Arms
ArmTypeDescription
Standard Nutrition ArmNO_INTERVENTIONIn ICU: 1. After enrolment, patients allocated to the standard nutrition therapy (control) group will commence or continue nutrition via an enteral tube to a target rate according to unit protocol including the use of promotility agents and the placement of nasojejunal feeding tubes if required. 2. PN will only be used if the above methods have been attempted, or an absolute contraindication to EN develops. 3. Unless there is specific indication for a compounded PN solution, the PN used in the standard care group will be the same as used in the intervention arm. After ICU: 1. Nutrition management will be as per usual site management at that hospital. 2. Nutrition intake amounts will be recorded 3 times per week using provided study documents and assessment tools.
Intensive ArmEXPERIMENTALIntervention In ICU: 1. Supplemental PN will be commenced within 2 hours of randomisation. The starting dose of PN will be determined by the amount of energy received in the 24 hours prior to randomisation 2. The need for the intervention will be based on the adequacy of nutrition provision from both PN and EN and assessed daily until ICU discharge 3. If there is an actual or anticipated interruption of EN for greater than 2 hours the PN must be run at 20 kcal/kg calculated body weight until EN is recommenced. After the interruption, EN should be recommenced as per local protocol. After ICU: An intensive nutrition intervention will be provided on the ward in the intervention group. This will include daily review from dedicated study dietitians and a clearly protocolized hierarchical management plan which reflects best practice clinical management.
Interventions
NameTypeDescription
Supplemental parenteral nutritionDIETARY_SUPPLEMENTSupplemental parenteral nutrition OLIMEL N12E (Baxter Healthcare Corporation)
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — N/A
SexALL
Healthy VolunteersNo
Study Sites23

Inclusion criteria Patients in intensive care who meet all of the following will be eligible: 1. Admitted to intensive care between 72 hours and 120 hours 2. Receiving invasive ventilator support 3. At least 18 years of age 4. Have central venous access suitable for PN solution administration 5. H...

Countries:AustraliaNew Zealand
Unlock Eligibility Criteria